VEGFA and chronic kidney disease: Importantly, VEGF neutralization with soluble fms-like tyrosine kinase 1 (sFLT-1) (a soluble VEGF receptor) and HMGB1-neutralizing antiserum attenuated other organ injury including the liver and lungs and improved the survival of CKD-sepsis animals.